Telix Pharmaceuticals Limited Nonderivative Financial Liabilities Undiscounted Cash Flows
Telix Pharmaceuticals Limited (TLPPF) had Nonderivative Financial Liabilities Undiscounted Cash Flows of $752.05 million as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2026-02-20
- 2024-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 1.02B AUD.
- 2023-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 220.40M AUD.
AUD
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2024-12-31 | 1.02B AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 220.40M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2025-12-31 | $752.05M 20-F · filed 2026-02-20 |
| 2024-12-31 | $631.22M 20-F · filed 2026-02-20 |